This message was sent to ##Email##
|
|
|
|
Transplantoux celebrates its first decade in 2018. On the 15th of June 10 transplants and their companions, physicians and physiotherapists will leave for Mont Ventoux, France again. Transplantoux was founded in 2008 and has since grown into a movement campaign that wants to motivate transplants to move healthy on a regular basis. READ MORE
The 2018 ballot for ITNS membership is open through Friday June 29, 2018 at 12:01 AM CDT. Review the candidate information and cast your vote today!
Looking to fill a role in your hospital? Advertise your open position with ITNS. Check out the ITNS Career Center at http://itns.org/career-center/career-center
Pulmonology Advisor
Individuals with pulmonary fibrosis experienced better long-term outcomes with double lung transplantation compared with single lung transplantation up until age 70, according to a study published in The Annals of Thoracic Surgery.
Findings were assessed using a retrospective analysis of all pulmonary fibrosis lung transplants in the United Network for Organ Sharing (UNOS) Database between 1987 and 2015 (9191 out of 29,779 total lung transplants).
READ MORE
HealthDay News via Infectious Disease Advisor
Post-transplant hepatitis C treatment increases access to transplant and reduces waitlist time among hepatitis C-positive patients awaiting kidney transplantation, according to a study published online May 14 in the American Journal of Transplantation.
David M. Chascsa, M.D., from the Mayo Clinic in Phoenix, Ariz., and colleagues retrospectively reviewed the course of 36 hepatitis C-positive patients awaiting kidney transplantation at two large centers within the same health system.
READ MORE
Medical Xpress
The presence of certain antibodies in patients may suggest a higher risk of transplant rejection across multiple organ types, including the kidney, liver, heart and lungs, according to a new study published in PLOS Medicine.
"The field of transplantation will benefit from this study by being able to better determine the risk of rejection in some transplant patients," said co-author John Friedewald, MD, professor of Medicine in the Division of Nephrology and Hypertension and of Surgery in the Division of Organ Transplantation.
READ MORE
Medscape (free login required)
Another study has confirmed that autologous hematopoietic stem cell transplant (aHSCT) improves survival in patients with multiple myeloma (MM).
A retrospective analysis of California databases showed that overall survival (OS) for patients with MM who received a transplant was 73 months, significantly longer than the 48 months for those who did not.
READ MORE
By Keith Carlson
At a time in history when nursing shortages and nurse attrition can be devastating, healthcare organizations must find ways to attract and retain the best nurse candidates. We all know that high-quality nursing care and engaged nurse employees are crucial for patient satisfaction. With reimbursement often tied to patient satisfaction, the need to retain an excellent nursing workforce cannot be overstated.
READ MORE
News-Medical
Organ transplantation is often a recommended way out for many end-stage diseases. It is a very complex medical procedure wherein an organ is removed from the donor’s body and placed in the recipient’s body in order to replace the dysfunctional organ.
The main hurdle associated with the success rate of organ transplantation is rejection of the transplanted organ by the recipient’s immune system.
READ MORE
Nurse.com
Rebecca Love, MSN, RN, ANP, was surprised — and somewhat dismayed — when she discovered she was the only nurse among 200 participants at a three-day healthcare “hackathon,” a collaborative event involving a variety of software development experts.
The event, hosted by Tufts University in Boston in 2014, was filled with physicians, medical students, programmers and engineers who formed teams to develop new ideas and learn more about the basic principles of launching a new product.
READ MORE
Medscape (free login required)
Fecal microbiota transplantation might be an alternative to antibiotics for the first-line treatment of acute Clostridium difficile, according to a proof-of-concept study conducted by a team from Norway.
The researchers "actually showed that the transplant group had a more sustained response," said Colleen Kelly, MD, from the Lifespan Women's Medicine Collaborative and the Alpert Medical School in Providence, Rhode Island.
READ MORE
Missed last week's issue? See which articles your colleagues read most.
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
 7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|